参考文献/References:
[1] James SL,Global.Regional and national incidence prevalence and years lived with disability for 354 diseases and injuries for 195 countries and territories[J].The Lancet,2018,392(10159):1789-1858.
[2] Sata Y,Head GA,Denton K,et al.Role of the sympathetic nervous system and its modulation in renal hypertension[J].Front Med,2018,29(5):82.
[3] 中国医师协会心血管内科医师分会,中国心血管健康联盟,心肌梗死后心力衰竭防治专家共识工作组.心肌梗死后心力衰竭防治专家共识[J].中国循环杂志,2020,35(12):1166-1180.
[4] 张燕飞,张 博,陈苏宁.苓桂术甘汤加味联合卡托普利对慢性心力衰竭大鼠BNP、ET-1、Caspase-3水平影响的研究[J].陕西中医,2021,42(6):701-704.
[5] 李雪萍,张宝成,黄 聪,等.苓桂术甘汤对慢性心力衰竭大鼠Ang-Ⅱ、ET-1、BNP的影响[J].中西医结合心脑血管病杂志,2020,18(13):2063-2067.
[6] 唐薪骐.苓桂术甘汤对心力衰竭大鼠内质网应激及细胞凋亡作用机制研究[D].沈阳:辽宁中医药大学,2020.
[7] 李 苗,张 妍,雷瑗琳.心脾同治在慢性心力衰竭治疗中的应用进展[J].陕西中医,2021,42(6):814-816.
[8] 冷 赢.心脏导引术联合苓桂术甘汤对慢性心衰患者RAAS系统干预的临床研究[D].长沙:湖南中医药大学,2019.
[9] 纳丽莎,贾 梅,朱 睿,等.三维斑点追踪超声心动图定量评价成人肥厚型心肌病早期左室心肌收缩力学变化[J].宁夏医学杂志,2019,41(12):1060-1063.
[10] Naeije R,Badagliacca R.The overloaded right heart and ventricular interdependence[J].Cardiovasc Res,2017,113(12):1474-1485.
[11] Michael C.The non-fibrillar side of fibrosis:Contribution of the basement membrane proteoglycans and glycoproteins to myocardial fibrosis[J].Journal of Cardiovascular Development and Disease,2019,6(4):35.
[12] Webber M.Myocardial fibrosis in heart failure:Anti-fibrotic therapies and the role of cardiovascular magnetic resonance in drug trials[J].Cardiology and Therapy,2020,9(2):1-14.
[13] Adamcova M,Kawano I,Simko F.The impact of micrornas in renin-angiotensin-system-induced cardiac remodelling[J].International Journal of Molecular Sciences,2021,22(9):4762.
[14] 王 茹,王承龙.心室重构及其与能量代谢重构发生发展的关系[J].心脏杂志,2022,173(1):89-93.
[15] Opie LH,Commerford PJ,Gersh BJ,et al.Controversies in ventricular remodelling[J].The Lancet,2006,367(9507):356-367.
[16] 王志燕,陈 晨,吕 强,等.2021年ESC急慢性心力衰竭诊断与治疗指南解读[J].中华心血管病杂志,2021,49(12):1252-1255.
[17] Azad N,Lemay G.Management of chronic heart failure in the older population[J].Geriatr Cardiol,2014,11(4):329-337.
[18] Krumholz,Harlan M.Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission[J].Circulation Cardiovascular Quality and Outcomes,2009,2(5):407-413.
[19] Writing Group Members.Heart disease and stroke statistics-2016 update:A report from the american heart association[J].Circulation,2016,133(4):e38-e360.
[20] 刘晨萍,董耀荣,袁晨越.温阳利水法治疗中晚期慢性心力衰竭研究进展[J].陕西中医,2021,42(6):811-813.
[21] 陈 勇,王 洁,杨 彤,等.心衰病中西医研究进展[J].陕西中医,2022,43(1):134-136.
[22] 曾 蕾,樊明媛,龙 静,等.论苓桂术甘汤中妙用桂枝治慢性心力衰竭[J].世界科学技术-中医药现代化,2021,23(11):3956-3962.
[23] 王 岩,薛 莉.超声心肌做功评价左室收缩功能的临床研究进展[J].医疗卫生装备,2021,42(6):84-89.
[24] 周 芹,张国英,王 涛,等.无创心输出量监测仪和超声心动图在脓毒症患儿心功能评估中的相关性分析[J].中国小儿急救医学,2018,25(12):929-932,938.
[25] 李慕子,李 慧,孟 红,等.实时三维超声心动图自动定量技术评价肥厚型心肌病患者左心房容积及功能的应用价值[J].中国循环杂志,2022,37(5):487-493.
[26] 宋势波,欧阳斯华,李艺玲.超声心动图联合血清β2-微球蛋白、同型半胱氨酸评估扩张型心肌病患者心力衰竭风险的价值[J].临床超声医学杂志,2022,24(6):465-468.
[27] 梁梅馨.斑点追踪技术在评价小儿左室心肌力学方面的应用[J].医学理论与实践,2021,34(3):389-391.
[28] 刘淑军,陈小珠,康文慧.心脏超声常用切面中心肌带结构的分布状况[J].现代中西医结合杂志,2014,23(32):3555-3557.
[29] 丁 歆,曹衡玉.超声斑点追踪技术对评估2型糖尿病患者心脏收缩功能的影响[J].中国现代医生,2019,57(27):22-24.
[30] 林雪梅,李 丹,苏中州.超声心动图、N末端B型利钠肽原、心肺运动试验对经皮冠状动脉介入术后患者心功能评估的价值[J].陕西医学杂志,2020,49(10):1270-1272,1276.
[31] 王 蕾,柯剑林,赵可辉,等.2D-STE在评价急性心肌梗死后存活心肌及左室整体收缩功能中的价值[J].医学影像学杂志,2020,30(12):2198-2202.
[32] 陈迎春,李莉锦,尹 静,等.实时三维超声心动图联合二维斑点追踪技术对青年男性力量型运动员右室收缩功能的研究[J].实用医学杂志,2019,35(22):3531-3534,3539.
[33] Simse K,Ayse TN,Ozlem CT,et al.Evaluation of left ventricular functions with two-dimensional speckle-tracking echocardiography(2D-STE)and N-terminal Pro-BNP in diabetic children[J].The Turkish Journal of Pediatrics,2018,60(6):633-641.
[34] Burri MV,Gupta D,Kerber RE,et al.Review of novel clinical applications of advanced real-time 3-dimensional echocardiography[J].Journal of Laboratory and Clinical Medicine,2012,159(3):149-164.
相似文献/References:
[1]杨禹娟,张勇,吕军,等.益气复脉注射液治疗老年冠心病并发慢性心力衰竭30例[J].陕西中医,2016,(10):1325.
Yang Yujuan,Zhang Yong,Lv Jun,et al.[J].,2016,(9):1325.
[2]任红杰,赵安社,安谊沛,等.芪苈强心胶囊联合西药治疗慢性心力衰竭疗效及对患者NT-proBNP、hs-CRP、VEGF的影响*[J].陕西中医,2019,(6):711.
[3]隋艳波,凌丽云,刘 莉.“血不利则为水”理论论治心力衰竭研究[J].陕西中医,2021,(2):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
SUI Yanbo,LING Liyun,LIU Li.Treating heart failure based on the theory of “Unsmooth blood circulation results in water”[J].,2021,(9):213.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.019]
[4]陈仁山,肖惠珍,刘 宁,等.参芪扶正注射液抑制ERK1/2、GATA4信号通路改善小鼠心力衰竭实验研究[J].陕西中医,2022,(1):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
CHEN Renshan,XIAO Huizhen,LIU Ning,et al.Effect of Shenqi Fuzheng injection on heart failure in mice by inhibiting ERK1/2,GATA4 signaling pathway[J].,2022,(9):8.[doi:DOI:10.3969/j.issn.1000-7369.2022.01.002]
[5]尼苦王康,邓 兵.中药治疗射血分数保留的心力衰竭研究进展[J].陕西中医,2022,(3):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
NiKU Wangkang,DENG Bing.Research progress of traditional Chinese medicine in treating heart failure with preserved ejection fraction[J].,2022,(9):405.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.033]
[6]李 敏,刘福明,邢俊武,等.葶苈大枣泻肺汤合决渎汤治疗心力衰竭阳虚水泛证临床研究[J].陕西中医,2023,(6):721.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.008]
LI Min,LIU Fuming,XING Junwu,et al.Analysis of curative effect of Tingli Dazao Xiefei decoction and Juedu decoction in heart failure with yang deficiency and water flooding syndrome[J].,2023,(9):721.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.008]
[7]赵小云,李心仪,周春祥.苓桂术甘汤抑制脂多糖诱导小胶质细胞由M2向M1型极化作用机制[J].陕西中医,2023,(11):1503.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.002]
ZHAO Xiaoyun,LI Xinyi,ZHOU Chunxiang.Mechanism of Linggui Zhugan decoction on polarization of microglia from M2 to M1 induced by lipopolysaccharide[J].,2023,(9):1503.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.002]
[8]陈铭钦,雷瑗琳,师瑞瑞,等.益心附葶饮对慢性心力衰竭心肾阳虚证大鼠HIF-1/VEGF信号通路的影响[J].陕西中医,2023,(11):1527.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.007]
CHEN Mingqin,LEI Yuanlin,SHI Ruirui,et al.Effect of Yixin Futing Yin on HIF-1/VEGF signaling pathway in rats with chronic heart failure of Xinshen Yangxu syndrome[J].,2023,(9):1527.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.007]
[9]曹晓璇,胡佳裕,张钰欣,等.基于“三焦气化”论治老年心力衰竭利尿剂抵抗[J].陕西中医,2023,(11):1585.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.021]
[10]陈佳永,庞 延,潘朝锌,等.基于心肌能量代谢探讨中医药防治心力衰竭研究进展[J].陕西中医,2024,(7):1002.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.032]
CHEN Jiayong,PANG Yan,PAN Chaoxin,et al.Research progress of traditional Chinese medicine in prevention and treatment of heart failure based on myocardial energy metabolism[J].,2024,(9):1002.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.032]
[11]周 媛,李启注,徐京育.苓桂术甘汤治疗心力衰竭研究进展[J].陕西中医,2022,(12):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]
ZHOU Yuan,LI Qizhu,XU Jingyu.Overview of the clinical application of Linggui Zhugan prescription in the treatment of heart failure[J].,2022,(9):1819.[doi:DOI:10.3969/j.issn.1000-7369.2022.12.042]